• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性胆总管癌所致远端恶性胆道梗阻中行覆膜支架与裸支架的比较。

Covered vs bare stent for distal malignant biliary obstruction due to primary common biliary cancer.

机构信息

Department of Radiology. The Fourth People's Hospital of Taizhou, Taizhou.

Department of Interventional Radiology, Jiangyin People's Hospital, Jiangyin.

出版信息

Medicine (Baltimore). 2021 Jan 22;100(3):e23938. doi: 10.1097/MD.0000000000023938.

DOI:10.1097/MD.0000000000023938
PMID:33545967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7837960/
Abstract

This study was designed as a means of comparing the clinical efficacy and long-term outcomes of covered vs bare stent insertion as a treatment for distal malignant biliary obstruction (DMBO) caused by primary common biliary cancer (PCBC).This retrospective study was designed using data collected between January 2012 and December 2019 to assess the short- and long-term outcomes in patients with DMBO caused by PCBC treated by inserting either bare or covered stents were compared.Ninety two patients with DMBO caused by PCBC were divided between bare (n = 51) or covered (n = 41) stent groups. Technical success rates in both groups were 100%. Clinical success of bare vs covered stent use were 96.1% and 97.6% (P = 1.00). Stent dysfunction was seen in 17 and 6 patients in the bare and covered stent groups, respectively (P = .04). The median stent patency for bare and covered stents was 177 and 195 days, respectively (P = .51). The median survival was 188 and 200 days in the bare and covered stent groups, respectively (P = .85).For patients with DMBO caused by PCBC, using bare vs covered stents yields similar clinical efficacy and long term outcomes.

摘要

本研究旨在比较覆盖支架与裸支架置入治疗原发性胆管癌(PCBC)所致远端恶性胆道梗阻(DMBO)的临床疗效和长期结局。本回顾性研究采用 2012 年 1 月至 2019 年 12 月期间收集的数据设计,评估了 PCBC 所致 DMBO 患者接受裸支架或覆盖支架置入治疗的短期和长期结局。92 例 PCBC 所致 DMBO 患者分为裸支架(n=51)或覆盖支架(n=41)组。两组技术成功率均为 100%。裸支架与覆盖支架组的临床成功率分别为 96.1%和 97.6%(P=1.00)。裸支架和覆盖支架组分别有 17 例和 6 例患者出现支架功能障碍(P=0.04)。裸支架和覆盖支架的中位支架通畅时间分别为 177 天和 195 天(P=0.51)。裸支架和覆盖支架组的中位生存时间分别为 188 天和 200 天(P=0.85)。对于 PCBC 所致 DMBO 患者,使用裸支架与覆盖支架的临床疗效和长期结局相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f96/7837960/c5c8f66890f0/medi-100-e23938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f96/7837960/7b00354a5604/medi-100-e23938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f96/7837960/0312444bc127/medi-100-e23938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f96/7837960/c5c8f66890f0/medi-100-e23938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f96/7837960/7b00354a5604/medi-100-e23938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f96/7837960/0312444bc127/medi-100-e23938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f96/7837960/c5c8f66890f0/medi-100-e23938-g003.jpg

相似文献

1
Covered vs bare stent for distal malignant biliary obstruction due to primary common biliary cancer.原发性胆总管癌所致远端恶性胆道梗阻中行覆膜支架与裸支架的比较。
Medicine (Baltimore). 2021 Jan 22;100(3):e23938. doi: 10.1097/MD.0000000000023938.
2
Percutaneous biliary covered stent insertion in patients with malignant duodenobiliary obstruction.经皮胆道覆膜支架置入术治疗恶性十二指肠胆管梗阻患者
Acta Radiol. 2015 Feb;56(2):166-73. doi: 10.1177/0284185114523267. Epub 2014 Feb 11.
3
Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial.带防迁移系统的覆膜自膨式金属支架与未覆膜支架相比,可改善因胰腺癌导致的远端胆道梗阻的通畅时间,而不增加并发症:一项随机多中心试验。
Am J Gastroenterol. 2013 Nov;108(11):1713-22. doi: 10.1038/ajg.2013.305. Epub 2013 Sep 17.
4
Percutaneous transhepatic hybrid biliary endoprostheses using both plastic and metallic stents for palliative treatment of malignant common bile duct obstruction.经皮经肝联合使用塑料和金属支架的胆道内支架治疗恶性胆总管梗阻的姑息性治疗。
Eur J Cancer Care (Engl). 2013 Nov;22(6):782-8. doi: 10.1111/ecc.12088. Epub 2013 Jul 8.
5
Malignant Hilar Biliary Obstruction: Treatment by Means of Placement of a Newly Designed Y-Shaped Branched Covered Stent.恶性肝门部胆管梗阻:采用新设计的 Y 形分支覆膜支架置入术治疗
Cardiovasc Intervent Radiol. 2016 Apr;39(4):582-90. doi: 10.1007/s00270-015-1205-1. Epub 2015 Sep 10.
6
Covered biliary stents with proximal bare stent extension for the palliation of malignant biliary disease: can we reduce tumour overgrowth rate?近端裸支架延伸的覆膜胆管支架用于恶性胆管疾病的姑息治疗:我们能否降低肿瘤过度生长率?
Ann Palliat Med. 2017 Aug;6(Suppl 1):S58-S64. doi: 10.21037/apm.2017.06.03. Epub 2017 Aug 2.
7
Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction: A randomized controlled trial.具有抗移位特性的部分覆盖与未覆盖自膨式镍钛合金支架用于缓解恶性远端胆管梗阻:一项随机对照试验。
Scand J Gastroenterol. 2015;50(12):1490-9. doi: 10.3109/00365521.2015.1057219. Epub 2015 Jul 1.
8
Reintervention for occluded metal stent in malignant bile duct obstruction: A prospective randomized trial comparing covered and uncovered metal stent.恶性胆管梗阻中闭塞金属支架的再次干预:一项比较覆膜和非覆膜金属支架的前瞻性随机试验。
J Gastroenterol Hepatol. 2016 Nov;31(11):1901-1907. doi: 10.1111/jgh.13392.
9
Percutaneous Biliary Metallic Stent Insertion in Patients with Malignant Duodenobiliary Obstruction: Outcomes and Factors Influencing Biliary Stent Patency.经皮经肝胆道金属支架置入术治疗恶性十二指肠胆管梗阻患者:结局和影响胆道支架通畅的因素。
Korean J Radiol. 2020 Jun;21(6):695-706. doi: 10.3348/kjr.2019.0753.
10
Comparison of partially covered nitinol stents with partially covered stainless stents as a historical control in a multicenter study of distal malignant biliary obstruction: the WATCH study.多中心研究中远端恶性胆道梗阻的历史对照:WATCH 研究,比较覆膜镍钛合金支架与覆膜不锈钢支架。
Gastrointest Endosc. 2012 Jul;76(1):84-92. doi: 10.1016/j.gie.2012.02.039. Epub 2012 Apr 5.

本文引用的文献

1
Percutaneous transhepatic biliary drainage in patients at higher risk for adverse events: experience from a tertiary care referral center.经皮经肝胆道引流术在高风险不良事件患者中的应用:来自三级医疗转诊中心的经验。
Abdom Radiol (NY). 2020 Aug;45(8):2547-2553. doi: 10.1007/s00261-019-02344-1.
2
Self-Expanded Metallic Stent Insertion for Hilar Cholangiocarcinoma: Comparison of Unilateral and Bilateral Stenting.自膨式金属支架置入术治疗肝门部胆管癌:单侧与双侧支架置入的比较
J Laparoendosc Adv Surg Tech A. 2019 Dec;29(12):1501-1506. doi: 10.1089/lap.2019.0509. Epub 2019 Sep 24.
3
Percutaneous stenting for malignant hilar biliary obstruction: a randomized controlled trial of unilateral versus bilateral stenting.
经皮支架置入术治疗恶性肝门胆管梗阻:单侧与双侧支架置入术的随机对照试验。
Abdom Radiol (NY). 2019 Aug;44(8):2900-2908. doi: 10.1007/s00261-019-02010-6.
4
Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: A multicenter trial.不可切除恶性胆道梗阻的放疗支架与传统金属支架的比较:一项多中心试验。
J Hepatol. 2018 May;68(5):970-977. doi: 10.1016/j.jhep.2017.12.028. Epub 2018 Jan 10.
5
Study of self-expandable metallic stent placement intraluminal I seed strands brachytherapy of malignant biliary obstruction.研究自膨式金属支架管腔内 I 粒子条近距离放射治疗恶性胆道梗阻。
Surg Endosc. 2017 Dec;31(12):4996-5005. doi: 10.1007/s00464-017-5481-5. Epub 2017 Jun 22.
6
Percutaneous Transhepatic Biliary Stent Implantation for Obstructive Jaundice of Perihilar Cholangiocarcinoma: A Prospective Study on Predictors of Stent Patency and Survival in 92 Patients.经皮肝穿刺胆管支架植入术治疗肝门部胆管癌所致梗阻性黄疸:92例患者支架通畅及生存预测因素的前瞻性研究
J Vasc Interv Radiol. 2016 Jul;27(7):1047-1055.e2. doi: 10.1016/j.jvir.2016.02.035. Epub 2016 May 27.
7
A retrospective study assessing fully covered metal stents as first-line management for malignant biliary strictures.一项评估全覆膜金属支架作为恶性胆管狭窄一线治疗方法的回顾性研究。
Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1347-53. doi: 10.1097/MEG.0000000000000455.
8
Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction: A randomized controlled trial.具有抗移位特性的部分覆盖与未覆盖自膨式镍钛合金支架用于缓解恶性远端胆管梗阻:一项随机对照试验。
Scand J Gastroenterol. 2015;50(12):1490-9. doi: 10.3109/00365521.2015.1057219. Epub 2015 Jul 1.
9
Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single center.经皮经肝胆道金属支架置入术治疗恶性肝门部梗阻:单中心159例患者的疗效及预测因素分析
Cardiovasc Intervent Radiol. 2015 Jun;38(3):709-21. doi: 10.1007/s00270-014-0992-0. Epub 2014 Oct 24.
10
Clinical efficacy of metallic biliary stents combined with different anti-cancer treatments in the management of bile duct cancer.金属胆道支架联合不同抗癌治疗方法在胆管癌治疗中的临床疗效
Hepatogastroenterology. 2014 Jan-Feb;61(129):22-6.